secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001437749-25-001113
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharma board member Janet Rehnquist resigns; JGS Holdings gets board designation right
--------------------------------------------------------------------------------

- Janet Rehnquist resigned from the Board effective January 7, 2025; no disagreement with Company.
- Term sheet with JGS Holdings LLC (Sauer Nunes) grants right to designate a Board member.
- Management currently considering nominees from JGS Holdings for appointment to the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925001113/0001437749-25-001113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925001113/nrxp20250114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-001113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer